- CA$4.54m
- CA$6.56m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 30th Apr | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Izotropic Corporation is a Canada-based medical device company. The Company is engaged in the development and commercialization of IzoView, a computed tomography (CT) imaging system, which produces cross-sectional images that can be imaged in the 30 centi-meter aperture by computer reconstruction of x-ray transmission data for non-invasive visualization of tissue. The IzoView is for use in the non-invasive visualization of breast tissue, as an adjunct tool to mammography, by providing x-ray computer reconstructed images as an aid for qualified healthcare providers. The Company has not generated any revenue.
Directors
- Last Annual
- April 30th, 2024
- Last Interim
- April 30th, 2024
- Incorporated
- May 19th, 2016
- Public Since
- May 31st, 2018
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Canadian Securities Exchange- Shares in Issue
- 56,796,346
- Address
- Suite 424, 800-15355 24th Avenue, SURREY, V4A 2H9
- Web
- https://izocorp.com/
- Phone
- +1 6045429458
- Auditors
- Dale Matheson Carr-Hilton LaBonte LLP
Upcoming Events for IZO
Q2 2024 Izotropic Corp Earnings Release
Similar to IZO
Aquarius Surgical Technologies
Canadian Securities Exchange
Cannabix Technologies
Canadian Securities Exchange
Cognetivity Neurosciences
Canadian Securities Exchange
Gemina Laboratories
Canadian Securities Exchange
Imagin Medical
Canadian Securities Exchange
FAQ
What is the Izotropic share price?
As of Today at 21:53 UTC, shares in Izotropic are trading at CA$0.08. This share price information is delayed by 15 minutes.
How has the Izotropic share price performed this year?
Shares in Izotropic last closed at CA$0.08 and the price had moved by -65.96% over the past 365 days. In terms of relative price strength the Izotropic share price has underperformed the Toronto Stock Exchange 300 Composite Index by -70.21% over the past year.
What are the analyst and broker recommendations for Izotropic?
There is no consensus recommendation for this security.
Find out moreWhat is the Izotropic dividend yield?
Izotropic does not currently pay a dividend.
Does Izotropic pay a dividend?
Izotropic does not currently pay a dividend.
When does Izotropic next pay dividends?
Izotropic does not currently pay a dividend.
How do I buy Izotropic shares?
To buy shares in Izotropic you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Izotropic?
As of the previous close price of CA$0.08, shares in Izotropic had a market capitalisation of CA$4.54m.
Where are Izotropic shares listed?
Here are the trading details for Izotropic:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: IZO
What kind of share is Izotropic?
Based on an overall assessment of its quality, value and momentum Izotropic is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Izotropic share price forecast for 2024?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Izotropic share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Izotropic. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -48.88%.
As of the last closing price of CA$0.08, shares in Izotropic were trading -43.35% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Izotropic PE Ratio?
The Izotropic PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.08.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Izotropic?
We do not have data on Izotropic's directors